-
Je něco špatně v tomto záznamu ?
Neurofibromatosis type 2-associated meningiomas: an international multicenter study of outcomes after Gamma Knife stereotactic radiosurgery
N. Mohammed, YC. Hung, Z. Xu, T. Chytka, R. Liscak, M. Tripathi, D. Arsanious, CP. Cifarelli, M. Perez Caceres, D. Mathieu, H. Speckter, GU. Mehta, GP. Lekovic, JP. Sheehan
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, multicentrická studie
- MeSH
- dítě MeSH
- dospělí MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- meningeom etiologie chirurgie MeSH
- mladiství MeSH
- mladý dospělý MeSH
- nádory mozku etiologie chirurgie MeSH
- následné studie MeSH
- nemoci nervového systému etiologie MeSH
- neurofibromatóza 2 komplikace MeSH
- progrese nemoci MeSH
- radiochirurgie škodlivé účinky metody MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- věk při počátku nemoci MeSH
- výsledek terapie MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
OBJECTIVE: The management of neurofibromatosis type 2 (NF2)-associated meningiomas is challenging. The role of Gamma Knife radiosurgery (GKRS) in the treatment of these tumors remains to be fully defined. In this study, the authors aimed to examine the role of GKRS in the treatment of NF2-associated meningiomas and to evaluate the outcomes and complications after treatment. METHODS: Seven international medical centers contributed data for this retrospective cohort. Tumor progression was defined as a ≥ 20% increase from the baseline value. The clinical features, treatment details, outcomes, and complications were studied. The median follow-up was 8.5 years (range 0.6-25.5 years) from the time of initial GKRS. Shared frailty Cox regression was used for analysis. RESULTS: A total of 204 meningiomas in 39 patients treated with GKRS were analyzed. Cox regression analysis showed that increasing the maximum dose (p = 0.02; HR 12.2, 95% CI 1.287-116.7) and a lower number of meningiomas at presentation (p = 0.03; HR 0.9, 95% CI 0.821-0.990) were predictive of better tumor control in both univariable and multivariable settings. Age at onset, sex, margin dose, location, and presence of neurological deficit were not predictive of tumor progression. The cumulative 10-year progression-free survival was 94.8%. Radiation-induced adverse effects were noted in 4 patients (10%); these were transient and managed medically. No post-GKRS malignant transformation was noted in 287 person-years of follow-up. CONCLUSIONS: GKRS achieved effective tumor control with a low and generally acceptable rate of complications in NF2-associated meningiomas. There did not appear to be an appreciable risk of post-GKRS-induced malignancy in patients with NF2-treated meningiomas.
Department of Neurological Surgery CEDIMAT Hospital Santo Domingo Dominican Republic
Department of Neurological Surgery House Ear Institute Los Angeles California
Department of Neurological Surgery Na Homolce Hospital Prague Czech Republic
Department of Neurological Surgery University of Virginia Health System Charlottesville Virginia
Department of Neurological Surgery West Virginia University Morgantown West Virginia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012398
- 003
- CZ-PrNML
- 005
- 20220506130041.0
- 007
- ta
- 008
- 220425s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3171/2020.12.JNS202814 $2 doi
- 035 __
- $a (PubMed)34144518
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mohammed, Nasser $u 1Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia
- 245 10
- $a Neurofibromatosis type 2-associated meningiomas: an international multicenter study of outcomes after Gamma Knife stereotactic radiosurgery / $c N. Mohammed, YC. Hung, Z. Xu, T. Chytka, R. Liscak, M. Tripathi, D. Arsanious, CP. Cifarelli, M. Perez Caceres, D. Mathieu, H. Speckter, GU. Mehta, GP. Lekovic, JP. Sheehan
- 520 9_
- $a OBJECTIVE: The management of neurofibromatosis type 2 (NF2)-associated meningiomas is challenging. The role of Gamma Knife radiosurgery (GKRS) in the treatment of these tumors remains to be fully defined. In this study, the authors aimed to examine the role of GKRS in the treatment of NF2-associated meningiomas and to evaluate the outcomes and complications after treatment. METHODS: Seven international medical centers contributed data for this retrospective cohort. Tumor progression was defined as a ≥ 20% increase from the baseline value. The clinical features, treatment details, outcomes, and complications were studied. The median follow-up was 8.5 years (range 0.6-25.5 years) from the time of initial GKRS. Shared frailty Cox regression was used for analysis. RESULTS: A total of 204 meningiomas in 39 patients treated with GKRS were analyzed. Cox regression analysis showed that increasing the maximum dose (p = 0.02; HR 12.2, 95% CI 1.287-116.7) and a lower number of meningiomas at presentation (p = 0.03; HR 0.9, 95% CI 0.821-0.990) were predictive of better tumor control in both univariable and multivariable settings. Age at onset, sex, margin dose, location, and presence of neurological deficit were not predictive of tumor progression. The cumulative 10-year progression-free survival was 94.8%. Radiation-induced adverse effects were noted in 4 patients (10%); these were transient and managed medically. No post-GKRS malignant transformation was noted in 287 person-years of follow-up. CONCLUSIONS: GKRS achieved effective tumor control with a low and generally acceptable rate of complications in NF2-associated meningiomas. There did not appear to be an appreciable risk of post-GKRS-induced malignancy in patients with NF2-treated meningiomas.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věk při počátku nemoci $7 D017668
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a nádory mozku $x etiologie $x chirurgie $7 D001932
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a meningeom $x etiologie $x chirurgie $7 D008579
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nemoci nervového systému $x etiologie $7 D009422
- 650 _2
- $a neurofibromatóza 2 $x komplikace $7 D016518
- 650 _2
- $a radiochirurgie $x škodlivé účinky $x metody $7 D016634
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Hung, Yi-Chieh $u 1Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia
- 700 1_
- $a Xu, Zhiyuan $u 1Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia
- 700 1_
- $a Chytka, Tomas $u 2Department of Neurological Surgery, Na Homolce Hospital, Prague, Czech Republic
- 700 1_
- $a Liscak, Roman $u 2Department of Neurological Surgery, Na Homolce Hospital, Prague, Czech Republic
- 700 1_
- $a Tripathi, Manjul $u 3Department of Neurological Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India
- 700 1_
- $a Arsanious, David $u 4Department of Neurological Surgery, West Virginia University, Morgantown, West Virginia
- 700 1_
- $a Cifarelli, Christopher P $u 4Department of Neurological Surgery, West Virginia University, Morgantown, West Virginia
- 700 1_
- $a Perez Caceres, Marco $u 5Department of Neurological Surgery, Université de Sherbrooke, Centre de recherche du CHUS, Sherbrooke, Quebec, Canada
- 700 1_
- $a Mathieu, David $u 5Department of Neurological Surgery, Université de Sherbrooke, Centre de recherche du CHUS, Sherbrooke, Quebec, Canada
- 700 1_
- $a Speckter, Herwin $u 6Department of Neurological Surgery, CEDIMAT Hospital, Santo Domingo, Dominican Republic; and
- 700 1_
- $a Mehta, Gautam U $u 7Department of Neurological Surgery, House Ear Institute, Los Angeles, California
- 700 1_
- $a Lekovic, Gregory P $u 7Department of Neurological Surgery, House Ear Institute, Los Angeles, California
- 700 1_
- $a Sheehan, Jason P $u 1Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia
- 773 0_
- $w MED00002843 $t Journal of neurosurgery $x 1933-0693 $g Roč. 136, č. 1 (2022), s. 109-114
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34144518 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130033 $b ABA008
- 999 __
- $a ok $b bmc $g 1789830 $s 1163599
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 136 $c 1 $d 109-114 $e 20210618 $i 1933-0693 $m Journal of neurosurgery $n J Neurosurg $x MED00002843
- LZP __
- $a Pubmed-20220425